YahooOctober 22, 2026 at 4:23 PM NY5 Days Ago
Why Biohaven Catapulted 25% — And Why It Might Not Be Done Sprinting
Biohaven stock catapulted Thursday after the FDA said it would review the company's embattled drug, troriluzole.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
